SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude climbs amid reported tanker and energy-infrastructure attacks and fears of supply disruption around the Strait of Hormuz, with Ukraines strikes on Russian oil facilities adding to supply concerns. Traders are divided between those betting on further gains from persistent risks and those expecting a pullback if tensions ease, while some warn the rally looks crowded or overextended.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Discussion centers on GameStops warrants nearing their stated expiration: with shares below the exercise price, traders debate whether they will expire worthless or whether Ryan Cohen will extend or otherwise change the terms. Some view non-exercise as avoiding dilution, while warrant holders and skeptical shareholders worry about losses and criticize the lack of a company catalyst; attention also remains on whether shares can hold technical support.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Hot inflation readings and rising-yield concerns have pressured rate-sensitive small caps, with traders highlighting IWMs breakdown and heavy demand for puts. The community is split between expecting further downside and looking for an oversold bounce near support.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A tech-led relief rally after a sharp AI-related selloff has put QQQ in focus, with traders debating whether the volatile rebound signals recovery or is a temporary bounce. Upcoming megacap earnings are a key test, while concerns about AI infrastructure spending and weak market breadth sustain bearish views.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is drawing attention amid a semiconductor and AI-stock selloff, with traders citing concerns about AI infrastructure financing and Hock Tans warnings about capital constraints, as well as backlash to his casino remarks. The 10-year NTT DOCOMO VMware agreement is seen as positive by some, but debate remains split between bearish concerns about AVGOs weak performance and dip-buying optimism.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is drawing attention ahead of its earnings report, with traders focused on whether AI- and memory-driven equipment demand will support strong results and guidance. The discussion also centers on a rebound after a steep semiconductor-sector pullback, with dip buyers watching support while others remain cautious about volatility and the earnings reaction.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention amid a sharp AI-neocloud selloff tied to concerns about financing the data-center buildout and whether future returns will justify the spending; traders are debating whether its rebound is a durable recovery or a short-lived bounce. Some argue Nebius is better positioned than more debt-heavy peers, while others remain cautious about funding, cash flow and continued selling pressure.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention after a steep selloff to post-IPO lows, with traders citing staged lockup expirations and insider share sales as added selling pressure alongside a TD Cowen price-target cut. The bearish debate centers on OpenAI customer concentration and the companys ability to scale, while bulls point to its AI-chip technology and argue the shares are oversold.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to record lows is being linked by traders to weakening support for Trump ahead of the midterms, with many voicing bearish views and pointing to Truth Socials limited engagement and the companys weak business fundamentals. A smaller bullish contingent views the selloff as a buying opportunity and cites the planned TAE Technologies merger.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

HPE is drawing attention after a sharp selloff alongside enterprise-hardware peers, following Barclays downgrade and concerns that AI-related revenue gains may reflect higher hardware prices more than accelerating demand. Traders are split between viewing the decline as an overreaction and buying opportunityciting AI-server and networking prospectsand worrying that valuations and growth expectations have run ahead of fundamentals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA approval to expand Alpha Taus U.S. REGAIN trial in recurrent glioblastoma from 10 to 20 patients is the main catalyst, alongside anticipated clinical data presentations and readouts. Traders are broadly bullish on the trials early results and the wider pipeline, though the GBM evidence remains preliminary and based on a small patient group.

New Strong Sell Stocks for July 7th

AMPX, DRTS and BELFB have been added to the Zacks Rank #5 (Strong Sell) List on July 7, 2026.

New Strong Sell Stocks for July  2nd

DRTS, CANG and LAZ have been added to the Zacks Rank #5 (Strong Sell) List on July 2, 2026.

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic...

DRTS Stock Shot Up A Whopping 22% Today – Why A $196.5M Prostate Cancer Deal Got Investors Buzzing

Equity

Alpha Tau signed an agreement with Tolmar to commercialize its lead cancer therapy for prostate cancer in the United States.

DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week

An extract featuring safety and efficacy results from three studies evaluating its key therapy for pancreatic cancer will be unveiled on Thursday.

Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally

Alpha Tau Medical stock surged after interim glioblastoma data showed complete responses in two patients treated with Alpha DaRT.read more...

DRTS Stock Surges Pre-Market Even As Retail Traders Debate ‘Too Small’ Brain Cancer Trial Data 

The biotech company’s experimental treatment for recurrent glioblastoma resulted in complete responses in 2 of the first 3 patients.

Nasdaq, S&P 500 Futures Dip As Trump-Iran Tensions Lift Crude Oil Prices: Why MU, MRAM, MLTX, DRTS, ASTS Are In Focus

Data from Stocktwits shows that retail traders’ sentiment has remained ‘bullish’ on SPY and QQQ, following last week’s resilience in tech and AI-linked names. 


DRTS Stock Rises Overnight: Early US Brain Cancer Trial Results Expected Today

Last week, Alpha Tau Medical completed enrollment in its ReStart study for recurring skin cancer.

Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Still a Buy?

Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Here's Why...

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

Bullish Sentiment

<ul class="summary-bullets"><li>Tolmar will invest $20 million in Alpha Tau at $11.99 per share, representing a 34% premium to the stock’s closing price on Tuesday.</li><li>The deal also includes up to $161.5 million in potential development, regulatory, and commercial milestones.</li><li>Tolmar will also have the option for a similar deal for bladder cancer indication in the future.</li></ul>Shares of Alpha Tau Medical (DRTS) surged more than 22% on Wednesday, after the widely tracked biotech firm announced a landmark deal with Tolmar to commercialize its lead cancer therapy for prostate cancer in the United States.Alpha Tau’s lead oncology therapy, Alpha DaRT, is being tested for the treatment of solid tumors.<h2 class="st-heading-2">Tolmar To Get Exclusive Rights For Commercialization</h2>Tolmar, a specialty pharmaceutical firm focused on urology and oncology products, will receive exclusive U.S. commercialization rights for Alpha DaRT in prostate cancer, with an option to expand into bladder cancer.Alpha Tau will lead clinical development and remain responsible for manufacturing the therapy, while Tolmar will oversee sales and commercialization efforts.As part of the agreement, Tolmar will invest $20 million in Alpha Tau at $11.99 per share, representing a 34% premium to the stock’s closing price on Tuesday, and contribute an additional $15 million toward expanding U.S. manufacturing capacity.The deal also includes up to $161.5 million in potential development, regulatory, and commercial milestones. This takes the overall commitment to $196.5 million.<h2 class="st-heading-2">Alpha DaRT Shows Promising Results In Pancreatic Cancer Study</h2>Earlier this week, Alpha Tau reported encouraging results from a pooled analysis of three Phase I/II studies evaluating its Alpha DaRT therapy in patients with pancreatic cancer. The data showed a median overall survival of 11.2 months for metastatic patients.The therapy also demonstrated a favorable safety profile, with treatment-related adverse events reported in 36% of patients and severe Grade 3 or higher events in just 9%. No treatment-related deaths or chronic toxicities were observed, and all severe adverse events were resolved.<h2 class="st-heading-2">What Does Retail Think Of DRTS?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/DRTS">DRTS</a> on Stocktwits remained in the ‘bullish’ territory over the past 24 hours.One user said the news was “fantastic on so many levels.”<stembedurl>https://stocktwits.com/Herbgator/message/655247664</stembedurl>However, another user noted that volumes traded were relatively low.<stembedurl>https://stocktwits.com/Olivia_Strickland/message/655257581</stembedurl>Around 0.6 million shares changed hands, compared to the daily average of more than one million shares, according to Stocktwits data.DRTS shares have soared around 114% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/iren-stock-hits-highest-levels-in-nearly-7-months-what-s-got-investors-buzzing/cZ0j4UQRext">IREN Stock Hits Highest Levels In Nearly 7 Months – What’s Got Investors Buzzing?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

Why Did DRTS Stock Surge 22% Today?

ALPHA TAU MEDICAL LTD

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$12.62
Prev Close	$12.29
Open	$12.56
Dividend Yield	0.00%
50-Day Moving Average	$14.44
Beta	0.83
Avg. Volume	509,675.01
PE Ratio	-12.14

52-Week High	$15.79
52-Week Low	$3.43
Market Capitalization	$1.14B
EPS (Annual)	-$0.529
Price to Book	26.45
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

DRTS Fundamentals